Skip Navigation

ALTEX: Current Issue 2013: Vol 30, No. 3


(All Articles are in PDF)

Sonja von Aulock


Thomas Hartung:
Look back in anger – what clinical studies tell us about preclinical work


Barae Jomaa, Jac M. M. J. G. Aarts, Laura H. J. de Haan, Ad A. C. M. Peijnenburg, Toine F. H. Bovee, Albertinka J. Murk, and Ivonne M. C. M. Rietjens:
In vitro pituitary and thyroid cell proliferation assays and their relevance as alternatives to animal testing

Sebastian Polak:
In vitro to human in vivo translation – pharmacokinetics and pharmacodynamics of quinidine

Karin Dreisig, Camilla Taxvig, Mia Birkhøj Kjærstad, Christine Nellemann, Ulla Hass, and Anne Marie Vinggaard:
Predictive value of cell assays for developmental toxicity and embryotoxicity of conazole fungicides

Miriam N. Jacobs, Susan C. Laws, Kate Willett, Pat Schmieder, Jenny Odum, and Toine F. Bovee:
In vitro metabolism and bioavailability tests for endocrine active substances: What is needed next for regulatory purposes?


Louise Parks Saldutti, Bruce K. Beyer, William Breslin, Terry R. Brown, Robert E. Chapin, Sarah Campion, Brian Enright, Elaine Faustman, Paul M. D. Foster, Thomas Hartung, William Kelce, James H. Kim, Elizabeth G. Loboa, Aldert H. Piersma, David Seyler, Katie J. Turner, Hanry Yu, Xiaozhong Yu, and Jennifer C. Sasaki:
In vitro testicular toxicity models: Opportunities for advancement via biomedical engineering techniques


Francesca Caloni, Patrizia Costa, Gianni Dal Negro, Isabella De Angelis, Silvia Dotti, Giovanna Lazzari, Giacomo Metteucci, and Augusto Vitale:
Alternative Methods: 3Rs, Research and Regulatory Aspects


Daniel R. Dietrich, Sonja von Aulock, Hans Marquardt, Bas Blaauboer, Wolfgang Dekant, James Kehrer, Jan Hengstler, Abby Collier, Gio Batta Gori, Olavi Pelkonen, Florian Lang, Frans P. Nijkamp, Kerstin Stemmer, Albert Li, Kai Savolainen, A. Wallace Hayes, Nigel Gooderham, and Alan Harvey:
Scientifically unfounded precaution drives European Commission’s recommendations on EDC regulation, while defying common sense, well-established science and risk assessment principles

Federico M. Stefanini:
Bayesian Network Integrated Testing Strategy and beyond

Joanna Jaworska:
Reply to: Bayesian Network Integrated Testing Strategy and beyond


Nina Hasiwa, Mardas Daneshian, Peter Bruegger, Stefan Fennrich, Astrid Hochadel, Sebastian Hoffmann, Felix E. Rivera-Mariani, Christoph Rockel, Stefanie Schindler, Ingo Spreitzer, Sandra Stoppelkamp, Kranthi Vysyaraju, and Thomas Hartung:
Evidence for the detection of non-endotoxin pyrogens by the whole blood monocyte activation test

New ALTEX: 3/2017
ALTEX 3/2017 cover

Support ALTWEB, Make a Gift
Online Humane Science Course


FRAME Training School in Experimental Design and Statistical Analysis
May 31-June 2, 2017
Saskatoon, Canada

Advances in Cell and Tissue Culture 2017
May 22-24, 2017
Manchester, UK

CAAT Academy
In Vitro Skin and Eye Models Hands-on Training
June 1-2 2017
Brussels, Belgium

CAAT Academy
Tools for Read-Across
June 15-16, 2017
Helsinki, Finland

ecopa SSCT Workshop 2017
June 14-16, 2017
Helsinki, Finland
Thomas Hartung will deliver a keynote address

CAAT Academy
Updates on Hepatotoxicity AOP Landscape and on the ADME Field - Season 2
June 22-23, 2017
Rennes, France

9th Euro-Global Summit on Toxicology and Applied Pharmacology
June 22-24, 2017
Paris, France
Email for Details

6th Annual Meeting of the American Society for Cellular and Computational Toxicology (ASCCT)
September 21-22
College Park, MD

10th World Congress on Alternatives and Animal Use in the Life Sciences
August 20-24, 2017
Seattle, Washington

CAAT Academy
Hands-on Training in Quantitative Human Cell and Effect-based In Vitro Bioanalysis for Assessing Endocrine-disrupting Compounds (EDCs)
September 7-8. 2017

More Meetings...